Myovant sciences Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Myovant sciences Contact Number

Myovant Sciences Contact Us, California Office

5 hours ago Myovant.com Get All

Website: https://www.myovant.com/contact-us/

Category: Contact SupportShow more

Myovant Sciences Redefining Care

4 hours ago Myovant.com Get All

Relugolix is a small molecule, gonadotropin-releasing hormone (GnRH) receptor antagonist, and an oral investigational drug candidate for the treatment of uterine fibroids, endometriosis, and …

Website: https://www.myovant.com/

Category: Contact NumberShow more

Myovant Sciences GmbH Company Profile Basel, …

5 hours ago Dnb.com Get All

Myovant Sciences GmbH is located in Basel, BASEL-STADT, Switzerland and is part of the Pharmaceutical and Medicine Manufacturing Industry. Myovant Sciences GmbH has 4 employees at this location and generates $976,312 in sales (USD). (Sales figure is modelled). There are 5 companies in the Myovant Sciences GmbH corporate family.

Employees: 4
Phone: 432155999
Location: Viaduktstrasse 8, Basel, 4051, BS

Website: https://www.dnb.com/business-directory/company-profiles.myovant_sciences_gmbh.c733f58684a6dec6d6fcc8a55e620828.html

Category: Contact NumberShow more

SMS Texting Terms and Conditions Myovant Sciences

6 hours ago Myovant.com Get All

As part of enrollment into the Myovant Sciences Patient Support Program SMS texting, an individual may contact Myovant Sciences for technical assistance or to request an additional text message that will include relevant contact information by replying “HELP” to the text message received.

Website: https://www.myovant.com/sms-privacy/

Category: Contact NumberShow more

Myovant Sciences Leadership

1 hours ago Myovant.com Get All

Dr. Arjona Ferreira has served as Chief Medical Officer of Myovant Sciences Ltd. and Myovant Sciences, Inc. since July 2017. From March 2014 to July 2017, Dr. Arjona Ferreira was Senior Vice President, Clinical Development at Shionogi Inc., a pharmaceutical company, where he served on its U.S. Senior Leadership Team and the Global Scientific

Estimated Reading Time: 10 mins

Website: https://www.myovant.com/our-company/our-leadership/

Category: Contact NumberShow more

Myovant Sciences Portal

8 hours ago Myovant-portal.idea-point.com Get All

At Myovant Sciences, we are committed to redefining care for women and for men through purpose-driven science, empowering medicines, and transformative advocacy. As part of that commitment, we recognize the value in collaborating with healthcare professionals, researchers and advocacy groups to fulfill this mission. We do this through our

Website: https://myovant-portal.idea-point.com/

Category: Contact NumberShow more

Privacy Policy Myovant Sciences

9 hours ago Myovant.com Get All

The types of personal information we collect and share depend on the nature of the relationship you have with Myovant and the requirements of applicable laws. The types of personal information we collect include: Contact and demographic information, such as your name, date of birth, age, gender, phone number, email and postal address

Website: https://www.myovant.com/privacy-policy/

Category: Contact NumberShow more

Myovant Sciences Announces European Commission …

7 hours ago Investors.myovant.com Get All

(650) 781-9106

Investor Contact: Ryan Crowe Vice President, Investor Relations Myovant Sciences, Inc. +1 (650) 781-9106 [email protected]myovant.com. Media Contact: Albert Liao Director, Corporate Communications Myovant Sciences, Inc. +1 (650) 410-3055 [email protected]myovant.com. Source: Myovant Sciences

Website: https://investors.myovant.com/news-releases/news-release-details/myovant-sciences-announces-european-commission-approval-ryeqor

Category: Contact NumberShow more

Myovant Sciences Ireland Limited Irish Company Info

8 hours ago Vision-net.ie Get All

Myovant Sciences Ireland Limited was set up on Monday the 3rd of April 2017. Their current partial address is Clare, and the company status is Normal. The company's current directors have been the director of 77 other Irish companies between them; 11 of which are now closed. Myovant Sciences Ireland Limited has 1 shareholder.

Website: https://www.vision-net.ie/Company-Info/Myovant-Sciences-Ireland-Limited-601541

Category: Contact NumberShow more

Myovant Sciences Crunchbase Company Profile & …

6 hours ago Crunchbase.com Get All

Founded Date 2016. Founders Lynn Seely. Operating Status Active. Last Funding Type Post-IPO Debt. Stock Symbol NYSE:MYOV. Company Type For Profit. Myovant Sciences is to deliver innovative women's health and prostate cancer solutions by efficiently advancing new medicines to market.

Website: https://www.crunchbase.com/organization/myovant-sciences

Category: Contact NumberShow more

SEC Filing Myovant Sciences Ltd.

4 hours ago Investors.myovant.com Get All

BASEL, Switzerland, July 28, 2021 -- Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women and for men, today announced corporate updates and financial results for the first quarter of fiscal year 2021.

Website: https://investors.myovant.com/node/9326/html

Category: Contact NumberShow more

Myovant Sciences Portal

4 hours ago Myovant-portal.idea-point.com Get All

Myovant Sciences Funding Requests Myovant Sciences is committed to the advancement of education for healthcare professionals and patients to enhance patient care. Myovant Sciences cannot provide any guidance as to whether a particular request will be approved or declined.

Website: https://myovant-portal.idea-point.com/Grants.aspx?groupid=GRANTS

Category: Contact NumberShow more

Myovant Sciences Portal

2 hours ago Myovant-portal.idea-point.com Get All

Myovant Sciences Investigator Initiated Studies (IIS) We are dedicated to improving the quality of human life and advancing medical sciences. As part of this commitment, we recognize the valuable role that our support of investigator-initiated studies (IIS) plays in fulfilling this mission. An investigator-initiated study is a research effort

Website: https://myovant-portal.idea-point.com/IIS.aspx?groupid=DEFAULT

Category: Contact NumberShow more

Myovant Sciences Portal

4 hours ago Myovant-portal.idea-point.com Get All

Portal Login. Email Address is required. Password is required. Forgot Password? ideaPoint V 5.5.0.

Website: https://myovant-portal.idea-point.com/Submissions.aspx

Category: Contact NumberShow more

Myovant Sciences and Gedeon Richter Enter into …

4 hours ago Investors.myovant.com Get All

Myovant Sciences, Inc. [email protected]myovant.com. Myovant Sciences Media Contact: Albert Liao Director, Corporate Communications Myovant Sciences, Inc. [email protected]myovant.com. Gedeon Richter Investor Contact: Katalin Ördög, +36 1 431 5680. Gedeon Richter Media Contact: Zsuzsa Beke, +36 1 431 4888. Source: Myovant Sciences, Inc.

Website: https://investors.myovant.com/news-releases/news-release-details/myovant-sciences-and-gedeon-richter-enter-exclusive-license

Category: Contact NumberShow more

Myovant Sciences LinkedIn

8 hours ago Ch.linkedin.com Get All

Myovant Sciences 12.532 Follower:innen auf LinkedIn We aspire to be the leading healthcare company focused on redefining care for women’s health and prostate cancer. Our experienced team brings significant breadth and depth of expertise in drug development, combined with a commitment to develop new treatments for women suffering from uterine fibroids, endometriosis, and infertility, and

Website: https://ch.linkedin.com/company/myovant-sciences

Category: Contact NumberShow more

SEC Filing Myovant Sciences Ltd.

4 hours ago Investors.myovant.com Get All

You are cordially invited to attend the Myovant Sciences Ltd. 2021 Annual General Meeting of Shareholders (the “Annual Meeting”). The Annual Meeting will be held at the Offices of Vistra UK Limited, 3rd Floor, 11-12 St. James’s Square, London SW1Y 4LB, United Kingdom on Friday, November 5, 2021 at 10:00 a.m. United Kingdom local time.

Website: https://investors.myovant.com/node/9336/html

Category: Contact NumberShow more

Myovant Sciences Appoints Uneek Mehra as Chief …

Just Now Ca.movies.yahoo.com Get All

(650) 781-9106

Investor Contact: Ryan Crowe Vice President, Investor Relations Myovant Sciences, Inc. +1 (650) 781-9106 [email protected]myovant.com. Media Contact: Albert Liao Director, Corporate Communications Myovant Sciences, Inc. +1 (650) 410-3055 [email protected]myovant.com

Website: https://ca.movies.yahoo.com/myovant-sciences-appoints-uneek-mehra-200100781.html

Category: Contact NumberShow more

Document SEC

2 hours ago Sec.gov Get All

Myovant Sciences’ forward-looking statements are based on management’s current expectations and beliefs and are subject to a number of risks, uncertainties, assumptions and other factors known and unknown that could cause actual results and the timing of certain events to differ materially from future results expressed or implied by the

Website: https://www.sec.gov/Archives/edgar/data/1679082/000167908221000008/a12312020myovantex991.htm

Category: Contact NumberShow more

SEC Filing Myovant Sciences Ltd.

4 hours ago Investors.myovant.com Get All

The reporting person undertakes to provide to Myovant Sciences Ltd. ("Myovant"), any security holder of Myovant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4: 3.

Website: https://investors.myovant.com/node/7921/html

Category: Contact NumberShow more

MYOVANT SCIENCES LTD. : Shareholders Board …

1 hours ago Marketscreener.com Get All

Myovant Sciences Ltd, is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing therapies for the treatment women’s health and endocrine diseases.

Website: https://www.marketscreener.com/quote/stock/MYOVANT-SCIENCES-LTD-31698733/company/

Category: Contact NumberShow more

Myovant Sciences Ltd Company Profile GlobalData

6 hours ago Globaldata.com Get All

View up-to-date information on Myovant Sciences Ltd’s latest deals, number of deals and deal values, alongside insights into key Myovant Sciences Ltd mergers and acqusitions. Unlock Full Profile.

Website: https://globaldata.com/company-profile/myovant-sciences-ltd/deals/

Category: Contact NumberShow more

Myovant Sciences and Pfizer Announce FDA …

2 hours ago Finance.yahoo.com Get All

Myovant Sciences’ forward-looking statements are based on management’s current expectations and beliefs and are subject to a number of risks, …

Website: https://finance.yahoo.com/news/myovant-sciences-pfizer-announce-fda-105800882.html

Category: Contact NumberShow more

Myovant Sciences Number of Employees 20172021 …

3 hours ago Macrotrends.net Get All

Myovant Sciences number of employees from 2017 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis

Website: https://www.macrotrends.net/stocks/charts/MYOV/myovant-sciences/number-of-employees

Category: Contact NumberShow more

Myovant Sciences Ltd Company Profile and News

9 hours ago Bloomberg.com Get All

Company profile page for Myovant Sciences Ltd including stock price, company news, press releases, executives, board members, and contact information

Website: https://www.bloomberg.com/profile/company/MYOV:US

Category: Contact NumberShow more

ORGOVYX™ (relugolix) Side Effects & Safety Data HCP

4 hours ago Orgovyxhcp.com Get All

1. QT/QTc Interval Prolongation:Androgen deprivation therapy, such as ORGOVYX may prolong the QT/QTc interval. Providers should consider whether the benefits of androgen deprivation therapy outweigh the potential risks in patients with congenital long QT syndrome, congestive heart failure, or frequent electrolyte abnormalities and in patients taking drugs known to prolong the QT interval. Electrolyte abnormalities should be corrected. Consider periodic monitoring of electrocardiograms and electrolytes. Embryo-Fetal Toxicity:The safety and efficacy of ORGOVYX have not been established in females. Based on findings in animals and mechanism of action, ORGOVYX can cause fetal harm and loss of pregnancy when administered to a pregnant female. Advise males with female partners of reproductive potential to use effective contraception during treatment and for 2 weeks after the last dose of ORGOVYX Laboratory Testing:Therapy with ORGOVYX results in suppression of the pituitary gonadal system. R...

Website: https://www.orgovyxhcp.com/safety/

Category: Contact NumberShow more

Myovant Sciences Funding, Financials, Valuation & …

5 hours ago Crunchbase.com Get All

Myovant Sciences has raised a total of $200M in funding over 1 round. This was a Post-IPO Debt round raised on Aug 5, 2020. Myovant Sciences is registered under the ticker NYSE:MYOV . Myovant Sciences is funded by Dainippon Sumitomo Pharma.

Website: https://www.crunchbase.com/organization/myovant-sciences/company_financials

Category: Contact NumberShow more

Myovant bumps IPO to $218M with Pfizer, BB Biotech …

8 hours ago Fiercebiotech.com Get All

In the IPO, Myovant sold 14.5 million shares, up from a previously expected 13 million. Those went at $15 apiece, the top of its anticipated range, to raise $218 million. That values the company

Website: https://www.fiercebiotech.com/biotech/myovant-bumps-up-ipo-to-218m-pfizer-bb-biotech-aid

Category: Tech SupportShow more

Myovant Sciences Announces European Commission …

2 hours ago Finance.yahoo.com Get All

Myovant Sciences’ forward-looking statements are based on management’s current expectations and beliefs and are subject to a number of risks, …

1. Author: Myovant Sciences, Inc.

Website: https://finance.yahoo.com/news/myovant-sciences-announces-european-commission-060000237.html

Category: Contact NumberShow more

Myovant Sciences to Host Webcast and Conference …

6 hours ago Finance.yahoo.com Get All

Investor Contact: Frank Karbe President, Chief Financial Officer Myovant Sciences, Inc. [email protected]myovant.com. Media Contact: Albert Liao Director, Corporate Communications

Website: https://finance.yahoo.com/news/myovant-sciences-host-webcast-conference-200510735.html

Category: Contact NumberShow more

Myovant Sciences Submits New Drug Application …

7 hours ago Finance.yahoo.com Get All

Myovant Sciences’ forward-looking statements are based on management’s current expectations and beliefs and are subject to a number of risks, …

Website: https://finance.yahoo.com/news/myovant-sciences-submits-drug-application-123010608.html

Category: Contact NumberShow more

Myovant (MYOV), Pfizer Start Dosing in Relugolix …

Just Now Nasdaq.com Get All

Myovant Sciences MYOV and partner Pfizer Inc. PFE announced that the first participant has been dosed in the late-stage study evaluating the contraceptive efficacy of …

Website: https://www.nasdaq.com/articles/myovant-myov-pfizer-start-dosing-in-relugolix-combo-study-2021-04-13

Category: Contact NumberShow more

Amended Statement of Beneficial Ownership (sc 13d/a)

1 hours ago Ih.advfn.com Get All

Myovant Sciences Ltd. (Name of Issuer) Common Shares, par value $0.000017727 per share (Title of Class of Securities) G637AM102 (CUSIP Number) Tsutomu Nakagawa. Senior Director, Global Corporate Strategy. Sumitomo Dainippon Pharma Co., Ltd. 6-8, Doshomachi 2-chome, Chuo-ku, Osaka 541-0045, Japan. Copies to: Benjamin O. Lang. Jones Day. The

Website: https://ih.advfn.com/stock-market/NYSE/myovant-sciences-MYOV/stock-news/86081297/amended-statement-of-beneficial-ownership-sc-13d-a

Category: Contact NumberShow more

Myovant Sciences hiring Associate Director/ Director

1 hours ago Linkedin.com Get All

Myovant Sciences aspires to be the leading healthcare company focused on innovative treatments for women’s health and prostate cancer designed to improve the lives of millions.

Website: https://www.linkedin.com/jobs/view/associate-director-director-early-clinical-development-operations-at-myovant-sciences-2708138115

Category: Contact NumberShow more

Myovant Sciences Announces Further Financing …

Just Now Finance.yahoo.com Get All

Myovant Sciences’ forward-looking statements are based on management’s current expectations and beliefs and are subject to a number of risks, …

Website: https://finance.yahoo.com/news/myovant-sciences-announces-further-financing-123000483.html

Category: Contact NumberShow more

UPDATE: Sumitovant Biopharma Announces Myovant …

2 hours ago Globenewswire.com Get All

Myovant Sciences' forward-looking statements are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties, assumptions and other factors known and

Website: https://www.globenewswire.com/news-release/2021/01/26/2164743/0/en/UPDATE-Sumitovant-Biopharma-Announces-Myovant-Sciences-Positive-One-Year-Data-from-Phase-3-SPIRIT-Extension-Study-of-Once-Daily-Relugolix-Combination-Therapy-in-Women-with-Endometr.html

Category: Contact NumberShow more

Myovant Sciences Ltd. 10K May. 18, 2020 4:20 PM …

9 hours ago Seekingalpha.com Get All

On December 27, 2019, we and our subsidiary, Myovant Sciences GmbH, Although there are a number of statutory exceptions and regulatory safe …

Website: https://seekingalpha.com/filing/5003546

Category: Contact NumberShow more

Myovant Sciences Ltd. (MYOV) CEO Dave Marek on Q1 …

5 hours ago Seekingalpha.com Get All

Myovant Sciences Ltd. (NYSE:MYOV) Q1 2021 Earnings Conference Call July 28, 2021 08:30 A.M.

Website: https://seekingalpha.com/article/4442066-myovant-sciences-ltd-myov-ceo-dave-marek-on-q1-2021-results-earnings-call-transcript

Category: Contact NumberShow more

Myovant Sciences Measures Up (NYSE:MYOV) …

9 hours ago Seekingalpha.com Get All

In a readout of LIBERTY 1 in May 2019, Myovant’s therapy achieved its primary endpoint with 73.4% of women (n=388) demonstrating blood loss volume of …

Website: https://seekingalpha.com/article/4341268-myovant-sciences-measures-up

Category: Contact NumberShow more

Myovant Sciences: Becoming A Blockbuster …

Just Now Seekingalpha.com Get All

1. As usual, I'll present a brief corporate overview for new investors. If you are familiar with the firm, I recommend that you skip to the subsequent section. Headquartered in Basel, Switzerland, Myovant is focused on the innovation and commercialization of medicines to serve the high unmet needs in women's health, endocrine diseases, and prostate cancer. I noted in the prior article: Figure 2: Therapeutic pipeline (Source: Myovant)

Website: https://seekingalpha.com/article/4432584-myovant-sciences-becoming-a-blockbuster

Category: Contact NumberShow more

Myovant Sciences Announces European Commission …

4 hours ago Apnews.com Get All

(650) 781-9106

Investor Contact: Ryan Crowe Vice President, Investor Relations Myovant Sciences, Inc. +1 (650) 781-9106 [email protected]myovant.com. Media Contact: Albert Liao Director, Corporate Communications Myovant Sciences, Inc. +1 (650) 410-3055 [email protected]myovant.com

Website: https://apnews.com/press-release/globe-newswire/europe-business-health-coronavirus-pandemic-european-commission-ef9491d02817a273cd0933cf47f2fec9

Category: Contact NumberShow more

Myovant Sciences Ltd. (MYOV) CEO Dave Marek on Q3 …

5 hours ago Seekingalpha.com Get All

Myovant Sciences Ltd. (NYSE:MYOV) Q3 2020 Earnings Conference Call February 11, 2021, 08:30 AM ET Company Participants Ryan Crowe - …

Website: https://seekingalpha.com/article/4405405-myovant-sciences-ltd-myov-ceo-dave-marek-on-q3-2020-results-earnings-call-transcript

Category: Contact NumberShow more

Pfizer Inc. Myovant Sciences and Pfizer Announce

5 hours ago Investors.pfizer.com Get All

Myovant Sciences' forward-looking statements are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties, assumptions and other factors known and unknown that could cause actual results and the timing of certain events to differ materially from future results expressed or implied by the forward

Website: https://investors.pfizer.com/investor-news/press-release-details/2021/Myovant-Sciences-and-Pfizer-Announce-Positive-Data-from-Phase-3-LIBERTY-Randomized-Withdrawal-Study-of-Once-Daily-Relugolix-Combination-Therapy-in-Women-with-Uterine-Fibroids/

Category: Contact NumberShow more

Myovant Sciences and Pfizer Announce FDA …

1 hours ago Biospace.com Get All

Myovant Sciences’ forward-looking statements are based on management’s current expectations and beliefs and are subject to a number of risks, uncertainties, assumptions and other factors known and unknown that could cause actual results and the timing of certain events to differ materially from future results expressed or implied by the

Website: https://www.biospace.com/article/releases/myovant-sciences-and-pfizer-announce-fda-acceptance-of-supplemental-new-drug-application-for-myfembree-for-the-management-of-moderate-to-severe-pain-associated-with-endometriosis/

Category: Contact NumberShow more

Initial Statement of Beneficial Ownership (3)

4 hours ago Ih.advfn.com Get All

1. Name and Address of Reporting Person * Mehra Uneek: 2. Date of Event Requiring Statement (MM/DD/YYYY) 9/7/2021 : 3. Issuer Name and Ticker or Trading Symbol Myovant Sciences Ltd. [MYOV] (Last) (First) (Middle) C/O MYOVANT SCIENCES INC., …

Website: https://ih.advfn.com/stock-market/NYSE/myovant-sciences-MYOV/stock-news/86020711/initial-statement-of-beneficial-ownership-3

Category: Contact NumberShow more

Insider Buying: Myovant Sciences Ltd. (NYSE:MYOV) …

1 hours ago Marketbeat.com Get All

Myovant Sciences Ltd. (NYSE:MYOV) major shareholder Chemical Co. Ltd. Sumitomo acquired 89,864 shares of the business's stock in a transaction dated Wednesday, September 15th. The stock was acquired at an average price of $21.98 per share, for a total transaction of $1,975,210.72. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at …

Website: https://www.marketbeat.com/instant-alerts/nyse-myov-insider-buying-and-selling-2021-09-2-3/

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

Who is the ceo of myovant sciences ltd?

Myovant Sciences Ltd. (NYSE: MYOV) Q3 2020 Earnings Conference Call February 11, 2021 8:30 AM ET Ryan Crowe - Vice President of Investor Relations Frank Karbe - President & Chief Financial Officer Adele Gulfo - Interim Chief Business and Commercial Development Office

What does myovant sciences funding and support portal do?

Welcome to the Myovant Sciences funding and support portal. At Myovant Sciences, we are committed to redefining care for women and for men through purpose-driven science, empowering medicines, and transformative advocacy.

When is myovant sciences first quarterly earnings call?

Myovant Sciences to Host First Fiscal Quarter 2021 Earnings Conference Call at 8:30 a.m. Eastern Time on July 28, 2021 Myovant Sciences and Pfizer Receive FDA Approval for MYFEMBREE®, the First Once-Daily Treatment for Heavy Menstrual Bleeding Associated With Uterine Fibroids

When does myovant expect phase 3 spirit data?

The application has completed validation and is now under evaluation by the EMA. Myovant expects top-line data from the Phase 3 SPIRIT 2 and SPIRIT 1 studies in women with pain associated with endometriosis in April and the second quarter of 2020, respectively.

Brand New Updated

Popular Brands

Merck
Man
Maaden
Mcx
Midea
Metro
Mapfre